STOCK TITAN
  1. Home
  2. Sec-filings
  3. PMN
  4. [EFFECT] ProMIS Neurosciences Inc. SEC Filing

[EFFECT] ProMIS Neurosciences Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 26, 2026 4:01 P.M.
Form: S-3
CIK: 0001374339
Company Name: ProMIS Neurosciences Inc.
File Number: 333-294408

Source: View Original Filing on SEC EDGAR

Promis Neuroscie

NASDAQ:PMN

View PMN Stock Overview →

PMN Rankings

#4816 Ranked by Market Cap
N/A Ranked by Dividends

PMN Latest News

Mar 25, 2026
ProMIS Neurosciences Announces Full Year 2025 Financial Results and Provides Corporate Highlights
Mar 18, 2026
ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer’s Disease/Parkinson’s Disease 2026 International Conference (AD/PD™)
Feb 4, 2026
ProMIS Neurosciences to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Jan 30, 2026
ProMIS Neurosciences Announces Up to $175 Million Private Placement Financing
Dec 18, 2025
ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 in Alzheimer’s Disease

PMN Latest SEC Filings

Mar 25, 2026
[S-3] ProMIS Neurosciences Inc. Shelf Registration Statement
Mar 25, 2026
[10-K] ProMIS Neurosciences Inc. Files Annual Report
Mar 25, 2026
[8-K] ProMIS Neurosciences Inc. Reports Material Event
Mar 18, 2026
[S-3] ProMIS Neurosciences Inc. Shelf Registration Statement
Mar 18, 2026
[SCHEDULE 13G] ProMIS Neurosciences Inc. Passive Investment Disclosure (>5%)

PMN Stock Data

135.68M
8.26M
Biotechnology
Pharmaceutical Preparations
Link
Canada
TORONTO